All of the following statements about nasiritide are true except:: (A) It is a BNP analogue, (B) It can be used in decompensated CHF, (C) It can be administered orally, (D) It causes loss of Na+ in the urine
Answer is C. Ref:CMTD 2014/936;KDT 6/e p507 Nesiritide is a recombinant BNP It reduces vasodilation and natriuresis it has to be administered by i.v. route.